Comparison between paricalcitol versus cinacalcet therapy in the management of secondary hyperparathyroidism among prevalent hemodialysis patients

Introduction: Secondary hyperparathyroidism (SHPT) is one of the components of chronic kidney disease–mineral bone disorder (CKD-MBD) with significant contribution to the morbidity and mortality among prevalent hemodialysis (HD) patients. Objectives: This multi-centric experience study aims to compa...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Maha A. Behairy, Osama Mahmoud, Ayman Rabie Ibrahim, Aber H. Baki
Formato: article
Lenguaje:EN
Publicado: Society of Diabetic Nephropathy Prevention 2022
Materias:
Acceso en línea:https://doaj.org/article/8a4ebf413edf4aa9a895d6a4a4301004
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!